Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 5Terminated 4Withdrawn 2Recruiting 2Unknown 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Colorectal Neoplasms 13Carcinoma, Hepatocellular 7Neoplasms 3Liver Neoplasms 2Glioblastoma 2Gastrointestinal Stromal Tumors 2Colonic Neoplasms 2Uterine Cervical Neoplasms 1Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Carcinoma 1Sarcoma, Ewing 1Rhabdomyosarcoma 1Recurrence 1Rectal Neoplasms 1Piebaldism 1Patient Compliance 1Pathologic Complete Response 1Ovarian Neoplasms 1Osteosarcoma 1Neoplasm Metastasis 1Multiple Myeloma 1Microsatellite Stable Metastatic Colorectal Cancer 1Meningioma 1Melanoma 1MCRC 1Lymphoma, Non-Hodgkin 1Lung Neoplasms 1Liver Metastases 1Leiomyosarcoma 1

Interventions

Oxaliplatin 13Bevacizumab 11Capecitabine 10Fluorouracil 8Blood Specimen Collection 8Leucovorin 7Cetuximab 7Folfox protocol 6pembrolizumab 5Drug Therapy 5trifluridine tipiracil drug combination 4dostarlimab 4Nivolumab 4Irinotecan 4HMPL-013 4fludarabine 3XELOX 3Specimen Handling 3IFL protocol 3Cyclophosphamide 3Biopsy 3toripalimab 2tislelizumab 2tipiracil 2regorafenib 2pertuzumab 2envafolimab 2encorafenib 2cemiplimab 2atezolizumab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Colonic Neoplasms × regorafenib × Clear all
NCT07003022 2025-06-04

Phase â…¡ Clinical Trial of Cadonilimab Combined With Anti-angiogenic Agents in Metastatic dMMR/MSI-H CRC

Fudan University

Phase 2 Recruiting
40 enrolled
Gastrointestinal

Colonic Neoplasms

NCT06425133 2024-12-24

CARE

Centre Hospitalier Universitaire de Besancon

Phase 2 Recruiting
174 enrolled
Gastrointestinal

Colonic Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡